| 0 (0%) | 12-05 10:02 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 109.81 | 1-year : | 128.26 |
| Resists | First : | 94.01 | Second : | 109.81 |
| Pivot price | 90.67 |
|||
| Supports | First : | 85.65 | Second : | 80.48 |
| MAs | MA(5) : | 90.51  |
MA(20) : | 89.87 |
| MA(100) : | 81.25 |
MA(250) : | 0 | |
| MACD | MACD : | 1.7 |
Signal : | 2 |
| %K %D | K(14,3) : | 46 |
D(3) : | 47.3 |
| RSI | RSI(14): 60.2 |
|||
| 52-week | High : | 94.01 | Low : | 61.24 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AZN ] has closed below upper band by 44.5%. Bollinger Bands are 29.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 91.13 - 91.63 | 91.63 - 92.04 |
| Low: | 88.18 - 88.91 | 88.91 - 89.5 |
| Close: | 88.97 - 90.04 | 90.04 - 90.91 |
Fri, 05 Dec 2025
SCS Capital Management LLC Purchases 142,331 Shares of AstraZeneca PLC $AZN - MarketBeat
Fri, 05 Dec 2025
Guggenheim Capital LLC Has $13.58 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Fri, 05 Dec 2025
Epoch Investment Partners Inc. Trims Position in AstraZeneca PLC $AZN - MarketBeat
Thu, 04 Dec 2025
AstraZeneca (Nasdaq: AZN) taps Salesforce Agentforce to unify global HCP engagement - Stock Titan
Thu, 04 Dec 2025
AstraZeneca (AZN) Could Benefit from FDA's Shift to Single Study Approval - GuruFocus
Thu, 04 Dec 2025
AstraZeneca (AZN) Set to Showcase Hematology Innovations at ASH 2025 - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 3,100 (M) |
| Shares Float | 1,540 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 16.7 (%) |
| Shares Short | 9,970 (K) |
| Shares Short P.Month | 7,000 (K) |
| EPS | 3 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 29.59 |
| Profit Margin | 16.1 % |
| Operating Margin | 24.1 % |
| Return on Assets (ttm) | 9 % |
| Return on Equity (ttm) | 21.6 % |
| Qtrly Rev. Growth | 12 % |
| Gross Profit (p.s.) | 15.61 |
| Sales Per Share | 18.75 |
| EBITDA (p.s.) | 6.58 |
| Qtrly Earnings Growth | 78 % |
| Operating Cash Flow | 15,140 (M) |
| Levered Free Cash Flow | 9,980 (M) |
| PE Ratio | 30.22 |
| PEG Ratio | 0 |
| Price to Book value | 3.07 |
| Price to Sales | 4.85 |
| Price to Cash Flow | 18.63 |
| Dividend | 0.5 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|